Platelet preservation composition containing eptifibatide, a reversible factor IIa inhibitor and a hemoglobin oxygen carrier

• US 7,964,338 B2
• Filed: 01/12/2006
• Issued: 06/21/2011
• Est. Priority Date: 01/12/2005
• Status: Expired due to Fees

• Current Assignee: Biovec Transfusion LLC
• Original Assignee: Biovec Transfusion LLC
• Inventors: Sehgal, Lakshman R., Mousa, Shaker
• Primary Examiner(s): SAUCIER, SANDRA E
• Application Number:
  US11/330,132
• Publication Number:
  US 20060177811A1
• Time in Patent Office: 1,986 Days
• Field of Search: None
• US Class Current: 435/2
• CPC Class Codes: A01N 1/02 Preservation of living parts
• CPC Class Codes: A01N 1/0215 Disinfecting agents, e.g. antimicrobials for preserving living parts
• CPC Class Codes: A01N 1/0226 Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients

Abstract

The present invention relates to compositions and methods for storing platelets to preserve the function and freshness of the platelets. More particularly, the present invention relates to the use of a preservative composition having an antiplatelet agent, an anticoagulant, and an oxygen carrier, for maintaining the freshness of platelets. Additionally, the composition may also contain an ultra-short acting broad spectrum anti-microbial agents. The preservative composition may be used to store platelets in a liquid state, a frozen state, or a freeze-dried state.

Claims

1. A platelet preservation composition, comprising:

a) a single antiplatelet agent;

b) an anticoagulant that reversibly inhibits factor IIa; and

c) a hemoglobin-based oxygen carrier at a concentration range of 1-18 gm/dl;

wherein said antiplatelet agent is eptifibatide and said composition is capable of extending the shelf-life of a platelet.

2. The composition of claim 1, wherein said antiplatelet agent is conjugated to a nitric oxide donor.

3. The composition of claim 1, wherein said antiplatelet agent has a circulating half-life of inhibition of about less than 4 hours.

4. The composition of claim 1, wherein said antiplatelet agent consists of about 0.001 mg to about 5 mg of eptifibatide.

5. The composition of claim 1, wherein said anticoagulant is a factor IIa inhibitor selected from the group consisting of hirudin, hirulog, melagatran, and combinations thereof.

6. The composition of claim 1, wherein said hemoglobin-based oxygen carrier is substantially free of red cell membrane contaminants.

7. The composition of claim 1, further comprising a anti-microbial agent selected from the group consisting of:

penicillin, monobactam, cephalosporins, carbapenems, vancomycin, isoniazid, ethambutol, aminoglycosides, tetracycline, chloramphenicol, macrolides, rifamycin, quinolone, fluoroquinolone, sulfonamides, polyene antibiotics, imidazole, triazole, griseofulvin and combinations thereof.